Akari Therapeutics Plc (AKTX)
8.225
+0.12
(+1.54%)
USD |
NASDAQ |
Oct 23, 16:00
8.235
+0.01
(+0.12%)
After-Hours: 20:00
Akari Therapeutics Market Cap : 14.40M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 14.40M |
| October 22, 2026 | 14.18M |
| October 21, 2026 | 15.33M |
| October 20, 2026 | 16.26M |
| October 19, 2026 | 17.31M |
| October 16, 2026 | 14.32M |
| October 15, 2026 | 15.47M |
| October 14, 2026 | 12.74M |
| October 13, 2026 | 13.83M |
| October 12, 2026 | 14.95M |
| October 09, 2026 | 15.35M |
| October 08, 2026 | 14.23M |
| October 07, 2026 | 15.10M |
| October 06, 2026 | 14.69M |
| October 05, 2026 | 15.65M |
| October 02, 2026 | 15.26M |
| October 01, 2026 | 15.47M |
| September 30, 2026 | 16.28M |
| September 29, 2026 | 17.01M |
| September 28, 2026 | 17.17M |
| September 25, 2026 | 17.08M |
| September 24, 2026 | 17.61M |
| September 23, 2026 | 16.91M |
| September 22, 2026 | 17.59M |
| September 21, 2026 | 16.42M |
| Date | Value |
|---|---|
| September 18, 2026 | 16.03M |
| September 17, 2026 | 17.29M |
| September 16, 2026 | 17.71M |
| September 15, 2026 | 17.94M |
| September 14, 2026 | 19.32M |
| September 11, 2026 | 19.78M |
| September 10, 2026 | 19.04M |
| September 09, 2026 | 18.50M |
| September 08, 2026 | 19.18M |
| September 04, 2026 | 20.08M |
| September 03, 2026 | 18.97M |
| September 02, 2026 | 17.77M |
| September 01, 2026 | 18.15M |
| August 31, 2026 | 18.26M |
| August 28, 2026 | 18.73M |
| August 27, 2026 | 15.77M |
| August 26, 2026 | 15.93M |
| August 25, 2026 | 13.78M |
| August 24, 2026 | 13.08M |
| August 21, 2026 | 13.74M |
| August 20, 2026 | 13.64M |
| August 19, 2026 | 13.83M |
| August 18, 2026 | 13.83M |
| August 17, 2026 | 13.16M |
| August 14, 2026 | 13.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 577.03M |
| Cellectis SA | 98.68M |
| Bicycle Therapeutics Plc | 178.84M |
| argenx SE | 54.07B |
| Autolus Therapeutics Plc | 409.89M |
Market Cap Related Metrics
| PEG Ratio | -0.0007 |
| Price to Book Value | 0.7742 |
| Price | 8.225 |
| Earnings Yield | -240.4% |
| PEGY Ratio | -0.0007 |